EGD showed gastric ulcer in antrum 1 cm without active bleeding or visible vessel.
Notably his H. pylori serology was positive on discharge.
HCT on discharge was 33.
He's had 1 black stool Monday, Tuesday, and 2 tarry stools on Wednesday.
NG lavage was not performed as patient declined, and patient had guaiac positive black stool.
HCT was 25.7.
CARDIAC RISK FACTORS: - Diabetes, + Dyslipidemia, - Hypertension 2.
-PERCUTANEOUS CORONARY INTERVENTIONS: [**2159**] mid RCA [**Year (4 digits) **].
2+DTR's-patellar and biceps  Pertinent Results: Admission Labs: [**2165-8-27**] 06:55AM   WBC-7.2 RBC-3.66* HGB-11.6* HCT-33.6* MCV-92 MCH-31.5 MCHC-34.4 RDW-14.2 [**2165-8-27**] 06:55AM   PLT COUNT-122* [**2165-8-27**] 06:55AM   PT-14.6* PTT-28.9 INR(PT)-1.3* [**2165-8-27**] 06:55AM   CALCIUM-8.2* PHOSPHATE-2.7 MAGNESIUM-1.7 [**2165-8-27**] 06:55AM   GLUCOSE-115* UREA N-27* CREAT-1.0 SODIUM-141 POTASSIUM-4.4 CHLORIDE-106 TOTAL CO2-29 ANION GAP-10 [**2165-8-27**] 01:00PM   HCT-33.0*  Imaging:  [**2165-8-29**] CXR: NG tube tip is in the stomach.
This should be confirmed with a repeat radiograph, PA and lateral views of the chest.
Brief Hospital Course: 60 yo M with CAD s/p [**Month/Day/Year **] to RCA in [**2164-12-24**] with known 1cm antral ulcer who presents with fatigue, HCT drop, and guaiac + black stool.
EGD on a previous admission showed gastritis and an antral ulcer.
He then underwent colonoscopy which showed no source of bleeding though it showed 2 polyps.
Hct stabilized in high 20's prior to transfer to floor.
He was given a capsule study which will be interpreted after discharge.
Patient's HCT remained stable x24h and he tolerated advancing diet so he was discharged.
Multiple other [**Year (4 digits) **] to LAD and LCx in the past.
You then underwent a colonoscopy which demonstrated two polyps but no evidence of bleeding.
You will need a followup colonoscopy in 3-6mos to remove those polyps.
Lastly, a capsule swallow study was done to assess the portion of the bowel not able to be visualized in egd or colonoscopy.
After these procedures, your hematocrit continued to be checked and was stable.
[**First Name7 (NamePattern1) **] [**Initial (NamePattern1) **] [**Last Name (NamePattern4) **] DO 12-BDU
